1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Autoimmune Drug Focus FEBRUARY 2016

Autoimmune Drug Focus FEBRUARY 2016

  • February 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Growing Strength Of Roche's Immunology Division Underlined By FY15 Results
Industry Trend Analysis - Janssen Collaboration Secures ViaCyte In Increasingly Competitive Research Arena
Industry Brief - Tresiba Significantly Lowers Hypoglycaemia Than Lantus In Phase IIIb Trial
Industry Brief - Fast Forward Pharmaceuticals Initiates FFP104 Phase II Trials in PBC/CD
Industry Trend Analysis - Cx601 Progressing In Development Race To Corner Blockbuster Market
Industry Trend Analysis - Digital Healthcare Partnerships Offer Expedited Development Potential
Industry Trend Analysis - Breakthrough Designation Affirms Ocrelizumab Blockbuster Potential
Industry Trend Analysis - Pfizer Edges Towards US Biosimilar Infliximab Dominance
Industry Brief - JHL Gains European Rituximab Trial Approval
Industry Brief - Sandoz Acquires Pfizer's Infliximab In EEA
Industry Brief - FDA Approves Pfizer's Xeljanz XR To Treat Moderate-To-Severe RA
Industry Brief - Dosing Begins In Ziarco's ZPL-389 Phase IIa Psoriasis Study
Industry Brief - Promius Pharma Gains Betamethasone Spray Approval
Industry Brief - NICE Recommends Ofev For IPF
Industry Brief - XTL Secures Israeli Patent Covering hCDR1 To Treat Lupus
Industry Trend Analysis - Diversification Key To Overcoming Tecfidera Reliance
Industry Trend Analysis - Generics Remain Essential For Teva As Copaxone Revenues Falter
Industry Brief - Autoimmune Conferences - May 2016

Table Of Contents

Autoimmune Drug Focus FEBRUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Monoclonal Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

Monoclonal Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

Global Monoclonal Antibody Therapeutics Market: Overview Monoclonal antibodies are a type of biological therapy used in the treatment serious conditions such as cancer, rheumatoid arthritis, Crohn’s ...

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. In this report, ...

Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments

Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments

  • $ 4995
  • Industry report
  • December 2016
  • by GBI Research

Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.